Most Accessed Articles: Thrombosis Journalhttps://thrombosisjournal.biomedcentral.comMost Accessed Articles: Thrombosis Journal- Heparin-induced thrombocytopenia: an updatehttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-3-14Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized....ReviewTue, 04 Oct 2005 00:00:00 GMThttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-3-14Massimo Franchini2005-10-04T00:00:00Z
- Laboratory assessment of rivaroxaban: a reviewhttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-11Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of whic...ReviewWed, 03 Jul 2013 00:00:00 GMThttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-11Meyer Michel Samama, Geneviève Contant, Theodore E Spiro, Elisabeth Perzborn, Lena Le Flem, Céline Guinet, Yves Gourmelin, Gabriele Rohde and Jean-Luc Martinoli2013-07-03T00:00:00Z
- Practical management of patients on apixaban: a consensus guidehttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-27Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence over 10% in older patients. AF is the leading preventable cause of ischaemic stroke, and strokes due to AF have a higher mor...ReviewTue, 31 Dec 2013 00:00:00 GMThttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-27Christopher Ward, Greg Conner, Geoffrey Donnan, Alexander Gallus and Simon McRae2013-12-31T00:00:00Z
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studieshttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-21Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic ...Original clinical investigationFri, 20 Sep 2013 00:00:00 GMThttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-21Martin H Prins, Anthonie WA Lensing, Rupert Bauersachs, Bonno van Bellen, Henri Bounameaux, Timothy A Brighton, Alexander T Cohen, Bruce L Davidson, Hervé Decousus, Gary E Raskob, Scott D Berkowitz and Philip S Wells2013-09-20T00:00:00Z
- Hereditary thrombophiliahttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-4-15Thrombophilia can be defined as a predisposition to form clots inappropriately. Thrombotic events during infancy and childhood are increasingly recognized as a significant source of mortality and morbidity. Th...ReviewTue, 12 Sep 2006 00:00:00 GMThttps://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-4-15Salwa Khan and Joseph D Dickerman2006-09-12T00:00:00Z